» Articles » PMID: 34840542

Green Nanoarchitectonics of Silver Nanoparticles for Antimicrobial Activity Against Resistant Pathogens

Overview
Publisher Springer
Date 2021 Nov 29
PMID 34840542
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial resistance represents a serious concern to public health, being responsible for hospital infections, affecting mainly immunosuppressed patients. Thus, nanotechnology appears as an alternative to solve this problem, through the application of metallic nanoparticles with antimicrobial activity. The present work aims to synthesize and characterize AgNPs from (AgNPs-KP) and extract (AgNPs-AV), evaluating the antimicrobial activity against carbapenemase (KpC) and the cytotoxicity in the L929 cell line. AgNPs were prepared by the biosynthetic method using and were characterized by XRD, FTIR and SEM-EDS. Antimicrobial activity was tested using the MIC and MBC. The cytotoxicity was evaluated by the MTT method and neutral red. The production of ROS and nitrogen RNS tests were performed in the L929 cell line. Thus, it was possible to confirm the production of AgNPs-KP, through morphological, structural and elemental analysis. AgNPs from had potent antimicrobial activity in low concentration against antimicrobial resistant pathogens with MIC 9.76 µg mL and MBC 9.06 µg mL. Moreover, AgNPs-KP in concentrations of 10, 30 and 100 µg mL did not show cytotoxic properties for the L929 fibroblast, where only the cytotoxic effect was observed in high concentrations (300 µg mL). AgNPs-KP did not produce ROS about the analyzed concentrations and RNS production was only in the highest concentration of 3000 µg mL. Therefore, AgNPs biosynthesized by have potential medical applicability as a promising antimicrobial agent, using a simple and low-cost method, correlating nanomedicine as nanostructured materials.

Citing Articles

Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics.

Rodrigues A, Batista J, Rodrigues M, Thipe V, Minarini L, Lopes P Front Microbiol. 2024; 15:1440065.

PMID: 39149204 PMC: 11325591. DOI: 10.3389/fmicb.2024.1440065.


Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems.

Guedes B, Krambeck K, Durazzo A, Lucarini M, Santini A, Oliveira M Braz J Microbiol. 2024; 55(3):2753-2766.

PMID: 38888693 PMC: 11405619. DOI: 10.1007/s42770-024-01410-1.


Phytochemical-Based Nanomaterials against Antibiotic-Resistant Bacteria: An Updated Review.

Diaz-Puertas R, Alvarez-Martinez F, Falco A, Barrajon-Catalan E, Mallavia R Polymers (Basel). 2023; 15(6).

PMID: 36987172 PMC: 10058650. DOI: 10.3390/polym15061392.


Light-emitting diode (LED)-directed green synthesis of silver nanoparticles and evaluation of their multifaceted clinical and biological activities.

Anjum S, Chaudhary R, Khan A, Hashim M, Anjum I, Hano C RSC Adv. 2022; 12(34):22266-22284.

PMID: 36043104 PMC: 9364226. DOI: 10.1039/d2ra03503k.

References
1.
Singh A, Gautam P, Verma A, Singh V, Shivapriya P, Shivalkar S . Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: A review. Biotechnol Rep (Amst). 2020; 25:e00427. PMC: 7005563. DOI: 10.1016/j.btre.2020.e00427. View

2.
Teoh M, Sun W, Smith B, Oberley L, Cullen J . Modulation of reactive oxygen species in pancreatic cancer. Clin Cancer Res. 2007; 13(24):7441-50. DOI: 10.1158/1078-0432.CCR-07-0851. View

3.
Arora S, Jain J, Rajwade J, Paknikar K . Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol. 2009; 236(3):310-8. DOI: 10.1016/j.taap.2009.02.020. View

4.
Carlson C, Hussain S, Schrand A, Braydich-Stolle L, Hess K, Jones R . Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008; 112(43):13608-19. DOI: 10.1021/jp712087m. View

5.
DErrico M, Lemma T, Calcagnile A, Proietti De Santis L, Dogliotti E . Cell type and DNA damage specific response of human skin cells to environmental agents. Mutat Res. 2006; 614(1-2):37-47. DOI: 10.1016/j.mrfmmm.2006.06.009. View